Interpreting the association between HIV and bone mineral density [8]

AIDS

Volumn 21, Issue 6, 2007, Pages 785-786

  Berg, Karina M ^a   Klein, Robert S ^a   Schoenbaum, Ellie E ^a   Arnsten, Julia H ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR;

BONE DENSITY; DISEASE ASSOCIATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMOBILIZATION; LETTER; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; WEIGHT REDUCTION;

BONE DENSITY; HIV INFECTIONS; HUMANS;

EID: 34147182666     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3280d6ee06     Document Type: Letter

References (5)

1. Brown TT, Qaqish RB. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS 2006; 20:2165-2174.
2. Struop DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000; 283:2008-2012.
3. Arnsten JH, Freeman R, Howard AA, Floris-Moore M, Santoro N, Schoenbaum EE. HIV infection and bone mineral density in middle-aged women. Clin Infect Dis 2006; 42:1014-1020.
4. Yin MT, Glesby MJ. Low bone mineral density, HIV infection, and women: fracture or fiction? Clin Infect Dis 2006; 42:1021-1023.
5. Arnsten JH, Freeman R, Howard AA, Floris-Moore M, Lo Y, Klein RS. Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS 2007; 21: in press.